Martingale Asset Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Sell
107,657
-2,265
-2% -$19.4K 0.03% 460
2025
Q4
$672K Buy
109,922
+17,185
+19% +$103K 0.02% 553
2025
Q3
$480K Sell
92,737
-31,467
-25% -$181K 0.01% 621
2025
Q2
$737K Buy
124,204
+62,318
+101% +$375K 0.02% 535
2025
Q1
$509K Buy
61,886
+47,146
+320% +$396K 0.01% 595
2024
Q4
$122K Buy
+14,740
New +$118K ﹤0.01% 751
2023
Q4
Sell
-73,774
Closed -$1.02M 838
2023
Q3
$1.02M Buy
73,774
+16,869
+30% +$247K 0.02% 429
2023
Q2
$681K Buy
+56,905
New +$642K 0.01% 538
2014
Q3
Sell
-25,513
Closed -$892K 889
2014
Q2
$892K Buy
+25,513
New +$838K 0.03% 559

Other funds holding PTEN

Martingale Asset Management's PTEN Position: Q1 2026 in Review

Martingale Asset Management reduced its Patterson-UTI (PTEN) stake by 2.1% in Q1 2026, selling an estimated $19.4K and leaving 107,657 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #460.

Martingale Asset Management first reported a position in PTEN in Q2 2014 and has held it in 9 quarters since. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Martingale Asset Management held 107,657 shares of Patterson-UTI worth $1.17M as of Q1 2026.
  • Martingale Asset Management sold 2,265 Patterson-UTI shares in Q1 2026, an estimated $19.4K.
  • Patterson-UTI made up 0.03% of Martingale Asset Management's portfolio in Q1 2026, its #460 holding.
  • Martingale Asset Management first reported a position in Patterson-UTI in Q2 2014 and has held it in 9 quarters since.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.